Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...
Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.
StockStory.org on MSN1d
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...
President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...
Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, ...
Healthcare pioneer Laura Shawver, Ph.D. appointed Chair of the Board and industry veteran Roy Baynes M.D., Ph.D. appointed as independent, non-exe ...
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe ...
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results